NO993383L - Ekspanderbart gastro-retentivt terapeutisk system med kontrollert frigiving av aktivt stoff i gastro-intestinaltrakten - Google Patents

Ekspanderbart gastro-retentivt terapeutisk system med kontrollert frigiving av aktivt stoff i gastro-intestinaltrakten

Info

Publication number
NO993383L
NO993383L NO993383A NO993383A NO993383L NO 993383 L NO993383 L NO 993383L NO 993383 A NO993383 A NO 993383A NO 993383 A NO993383 A NO 993383A NO 993383 L NO993383 L NO 993383L
Authority
NO
Norway
Prior art keywords
expandable
controlled release
active substance
retentive
gastro
Prior art date
Application number
NO993383A
Other languages
English (en)
Other versions
NO993383D0 (no
Inventor
Bodo Asmussen
Karsten Cremer
Karin Ludwig
Michael Roreger
Hans-Reiner Hoffmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO993383L publication Critical patent/NO993383L/no
Publication of NO993383D0 publication Critical patent/NO993383D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Abstract

Foreliggende oppfinnelse beskriver en innretning for kontrollert frigjøring av virkestoffer i gastrointestinalsystemet med forsinket pylomspassering med komponenter som er ekspanderbare ved kontakt med magesaft, og er omgitt av en polymerhinne som er permeabel for magesaft og virkestoffer. Innretningen inneholder minst et virkestoff som foreligger i en multipartikulær tilberedning, og avgir virkestoffet retardert i magesaften. I forhold til vanlig kjente legemiddelformer med forsinket pylomspassering kan virkestoff-frigjøringen i følge en innretning i oppfinnelsen bedre styres; likeledes lar innretningen seg lett rulle eller folde og kan uten problemer bli innført i kapsler.
NO993383A 1997-01-14 1999-07-08 Ekspanderbart gastro-retentivt terapeutisk system med kontrollert frigiving av aktivt stoff i gastro-intestinaltrakten NO993383D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19700915 1997-01-14
PCT/EP1998/000099 WO1998031341A1 (de) 1997-01-14 1998-01-09 Expandierbares gastroretentives therapie-system mit kontrollierter wirkstofffreisetzung im gastrointestinaltrakt

Publications (2)

Publication Number Publication Date
NO993383L true NO993383L (no) 1999-07-08
NO993383D0 NO993383D0 (no) 1999-07-08

Family

ID=7817288

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993383A NO993383D0 (no) 1997-01-14 1999-07-08 Ekspanderbart gastro-retentivt terapeutisk system med kontrollert frigiving av aktivt stoff i gastro-intestinaltrakten

Country Status (20)

Country Link
US (1) US6290989B1 (no)
EP (1) EP0961611B1 (no)
JP (1) JP3825811B2 (no)
KR (1) KR100503266B1 (no)
AT (1) ATE214916T1 (no)
AU (1) AU727753B2 (no)
CA (1) CA2277277C (no)
CZ (1) CZ297098B6 (no)
DE (2) DE19800523C2 (no)
DK (1) DK0961611T3 (no)
ES (1) ES2175676T3 (no)
HU (1) HU224224B1 (no)
ID (1) ID22698A (no)
IL (1) IL130872A (no)
NO (1) NO993383D0 (no)
NZ (1) NZ336691A (no)
PL (1) PL193282B1 (no)
PT (1) PT961611E (no)
SK (1) SK93999A3 (no)
WO (1) WO1998031341A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19822278A1 (de) * 1998-05-18 1999-12-02 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoff im Gastrointestinaltrakt mit verzögerter Pyloruspassage
DE19837073A1 (de) * 1998-08-17 2000-03-23 Lohmann Therapie Syst Lts Folienförmige Wirkstoffträger
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
DE19850309A1 (de) * 1998-10-30 2000-05-04 Lohmann Therapie Syst Lts Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer
DE19920833A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System mit quellbaren Polymeren
DE19920838A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System mit Kapillaren
DE19920854A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Verfahren und Vorrichtung zum Herstellen eines gastroretentiven flachen Schlauchbeutels mit Längsnaht
DE19920837A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System für verlängerte Verweilzeit im Magen bzw. im Gastrointestinaltrakt
DE19920855A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Magenvolumenreduzierende Darreichungsform
MXPA02007254A (es) 2000-02-04 2002-12-09 Depomed Inc Forma de dosis de cubierta-y-nucleo que se aproxima a liberacion de droga de orden cero.
GB0102725D0 (en) * 2001-02-02 2001-03-21 Stowic Resources Ltd Medical delivery system
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
WO2003051329A1 (de) * 2001-12-17 2003-06-26 Beisel Guenther Mittel zur oralen einnahme und verfahren zu dessen herstellung
US6869333B2 (en) * 2002-09-11 2005-03-22 National Optronics, Inc. Lens blank alignment and blocking device and method
US20040180086A1 (en) * 2002-10-11 2004-09-16 Zebunnissa Ramtoola Gastro-retentive levodopa delivery form
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
CA2574912A1 (en) * 2004-07-30 2006-02-02 Merrion Research Ii Limited Improved process and machine for automated manufacture of gastro-retentive devices
US8852083B2 (en) * 2005-02-04 2014-10-07 Uti Limited Partnership Self-stabilized encapsulated imaging system
KR100822519B1 (ko) * 2005-02-15 2008-04-16 주식회사종근당 위장 내에서 제어방출되는 단일 매트릭스 정제
CA2675230A1 (en) * 2006-01-10 2008-07-26 Pipex, Inc. Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases
US9579227B2 (en) * 2006-03-29 2017-02-28 Eat Little Inc. Ingestible implement for weight control
EP2004106B1 (en) * 2006-03-29 2012-05-30 Eatlittle Inc. Ingestible implement for weight control
WO2008074153A1 (en) * 2006-12-18 2008-06-26 Electronic Dietary Foods Inc. Device for delivery of a substance
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
US20120321706A1 (en) * 2009-10-19 2012-12-20 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
US20140343452A1 (en) * 2011-12-21 2014-11-20 Eatlittle Inc. Pseudobezoar-Based Intraluminal Gastrointestinal Cleansing and Biospy
AU2021396978A1 (en) 2020-12-08 2023-02-23 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
DE3400106A1 (de) 1984-01-04 1985-07-11 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
EP0283474A1 (de) * 1985-10-09 1988-09-28 Desitin Arzneimittel GmbH Verfahren zur herstellung einer darreichungs- und dosierungsform für arzneimittelwirkstoffe, reagentien oder andere wirkstoffe
IL87710A (en) * 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
DE3812799A1 (de) 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
WO1993012765A1 (en) * 1991-12-27 1993-07-08 Merck & Co., Inc. A controlled release drug dispersion delivery device
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen

Also Published As

Publication number Publication date
JP3825811B2 (ja) 2006-09-27
ATE214916T1 (de) 2002-04-15
CZ297098B6 (cs) 2006-09-13
JP2001508068A (ja) 2001-06-19
DK0961611T3 (da) 2002-07-15
ID22698A (id) 1999-12-09
IL130872A (en) 2004-02-19
CZ249599A3 (cs) 2000-01-12
HU224224B1 (hu) 2005-06-28
IL130872A0 (en) 2001-01-28
PL193282B1 (pl) 2007-01-31
WO1998031341A1 (de) 1998-07-23
DE19800523C2 (de) 1999-01-21
ES2175676T3 (es) 2002-11-16
PL334834A1 (en) 2000-03-27
AU6292298A (en) 1998-08-07
KR20000070179A (ko) 2000-11-25
HUP0000943A3 (en) 2000-11-28
CA2277277C (en) 2005-03-08
EP0961611A2 (de) 1999-12-08
PT961611E (pt) 2002-09-30
EP0961611B1 (de) 2002-03-27
NZ336691A (en) 2000-05-26
NO993383D0 (no) 1999-07-08
CA2277277A1 (en) 1998-07-23
HUP0000943A2 (hu) 2000-10-28
KR100503266B1 (ko) 2005-07-25
DE59803511D1 (de) 2002-05-02
SK93999A3 (en) 2000-01-18
DE19800523A1 (de) 1998-07-30
US6290989B1 (en) 2001-09-18
AU727753B2 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
NO993383L (no) Ekspanderbart gastro-retentivt terapeutisk system med kontrollert frigiving av aktivt stoff i gastro-intestinaltrakten
CA2344672A1 (en) Expandable gastroretentive therapy system having a prolonged gastric residence time
WO1998004249A3 (de) Tramadol multiple unit formulierungen
NO178095C (no) Fremgangsmåte for fremstilling av et omhyllet farmasöytisk retarderingspreparat
WO2006014973A3 (en) Pharmaceutical dosage forms including rasagiline
ATE357231T1 (de) Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitung
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
BG103138A (en) Tablets with controlled alphuzozine hydrochloride release
WO2002013784A3 (en) Drug delivery system with bilayer electrodes
NO163670C (no) Anordning for autoadministrering av fysiologisk aktive stoffer, med forhindring av overdosering.
WO2004035020A3 (en) Controlled release preparation
AU6872201A (en) Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
EE03904B1 (et) Graanul, farmatseutiline doseerimisvorm, graanulite valmistamismeetod ja ravimiga kaetud graanulid
HUP0204574A3 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity, pharmaceutical compositions containing them and their preparation
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
WO2001013898A3 (en) Pharmaceutical formulations with different release times
DK1171111T3 (da) Granulat, som har højt indhold af L-carnitin eller et alkanoyl L-carnitin, og som er særlig egnet til fremstilling af tabletter ved direkte presning
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
ATE234608T1 (de) Mikrokapseln mit verzögerter freisetzung von wirkstoffen
AU688823B2 (en) Adhesive patch for transdermal drug delivery
WO2000003702A8 (en) New pharmaceutical preparation and method
DK0979069T3 (da) Fremgangsmåde til fremstilling af peroralt anvendelige faste lægemiddelformer med styret afgivelse af aktivt stof
IT1227159B (it) Procedimento per prolungare la permanenza nel tratto gastrointestinale di farmaci in formulazioni ad effetto prolungato e forme di dosaggio cosi' ottenute.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application